ゲノムがんパネルとプロファイリングの世界市場レポート 2025年

ゲノムがんパネルとプロファイリング市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.7％で143億7,000万米ドルに成長します。予測期間における成長の原動力は、リキッドバイオプシー応用の拡大、早期発見における利用の拡大、テーラーメイド治療の継続的成長、コンパニオン診断薬承認の増加などが見込まれます。予測期間における主な動向としては、ゲノムデータ解釈のためのAIと機械学習の統合、マルチオミクスアプローチの開発、クラウドベースのゲノムデータ保存と解析、電子カルテとの統合、次世代シーケンサー（NGS）プラットフォームの拡大などが挙げられます。

がんの罹患率の増加がゲノムがんパネルとプロファイリング市場の成長を牽引すると予想されます。がんは、体内の異常細胞の制御不能な増殖と拡散を特徴とする疾患です。がん罹患率の上昇は、主に高齢化などの要因によるもので、高齢化により寿命が延びるとがんのリスクが高まる。ゲノムがんパネルやプロファイリングは、遺伝子変異やバイオマーカーの同定に使用され、個別化された治療計画を容易にし、早期発見や疾患モニタリングを改善します。例えば、2024年1月、米国がん協会は、2022年に世界で約2,000万人が新たにがんと診断され、970万人が死亡したと報告しました。人口増加に伴い、世界のがん罹患者数は2050年までに3,500万人に増加すると予測されています。したがって、がんの罹患率の増加は、ゲノムがんパネルとプロファイリング市場の成長を促進すると思われます。

ゲノムがんパネルとプロファイリング市場の主要企業は、がん診断の精度、スピード、網羅性を高める次世代シーケンサーなどの技術革新に注力しています。次世代シーケンサーは、遺伝子変異やその他のゲノムの特徴を特定するための遺伝物質の迅速かつハイスループットな解析を可能にする高度なDNA配列決定技術です。例えば、2025年4月、オランダのバイオテクノロジー企業であるQIAGEN N.V.は、次世代シーケンサー用に設計されたQIAseqパネルを発売しました。これらのパネルは700以上の遺伝子を分析することにより包括的なゲノム・プロファイリングを可能にし、がんの診断や治療戦略を改善するための研究および臨床応用の両方をターゲットとしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のゲノムがんパネルとプロファイリング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のゲノムがんパネルとプロファイリング市場：成長率分析
• 世界のゲノムがんパネルとプロファイリング市場の実績：規模と成長、2019年～2024年
• 世界のゲノムがんパネルとプロファイリング市場の予測：規模と成長、2024年～2029年、2034年
• 世界のゲノムがんパネルとプロファイリング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のゲノムがんパネルとプロファイリング市場：組織検査別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 固形組織検査
• 液体組織検査
• 世界のゲノムがんパネルとプロファイリング市場：技術別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 次世代シーケンシング（NGS）
• ポリメラーゼ連鎖反応（PCR）
• 蛍光in-situハイブリダイゼーション（FISH）
• 免疫組織化学（IHC）
• その他の技術
• 世界のゲノムがんパネルとプロファイリング市場：がんパネルの種類別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 単一遺伝子パネル
• マルチ遺伝子パネル
• 世界のゲノムがんパネルとプロファイリング市場：用途別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 臨床
• 研究
• 世界のゲノムがんパネルとプロファイリング市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院
• 研究・学術機関
• 臨床および診断検査室
• その他のエンドユーザー
• 世界のゲノムがんパネルとプロファイリング市場、固形組織検査の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 生検サンプル
• 外科的切除サンプル
• ホルマリン固定パラフィン包埋（FFPE）組織
• 新鮮凍結組織
• 世界のゲノムがんパネルとプロファイリング市場、液体組織検査の種類別のサブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 血
• 尿
• 唾液
• 脳脊髄液（CSF）
• その他の体液

第7章 地域別・国別分析

• 世界のゲノムがんパネルとプロファイリング市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界のゲノムがんパネルとプロファイリング市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ゲノムがんパネルとプロファイリング市場：競合情勢
• ゲノムがんパネルとプロファイリング市場：企業プロファイル
  • Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sysmex Corporation
• QIAGEN N.V.
• Exact Sciences Corporation
• ARUP Laboratories
• Tempus Labs
• Genscript Biotech Corporation
• NeoGenomics Inc.
• Foundation Medicine
• Invitae Corporation
• Guardant Health Inc.
• Caris Life Sciences
• Fulgent Genetics
• NanoString Technologies Inc.
• Genecast Biotechnology Co. Ltd
• Burning Rock DX

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ゲノムがんパネルとプロファイリング市場2029年：新たな機会を提供する国
• ゲノムがんパネルとプロファイリング市場2029年：新たな機会を提供するセグメント
• ゲノムがんパネルとプロファイリング市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Genomic cancer panel and profiling is a molecular diagnostic technique that simultaneously analyzes multiple genes to detect genetic mutations, alterations, or biomarkers linked to cancer. Its primary purpose is to guide personalized treatment decisions, predict disease progression, and enhance cancer diagnosis and monitoring.

The main tissue testing types in the genomic cancer panel and profiling market are solid tissue testing and liquid tissue testing. Solid tissue testing involves analyzing samples from solid tumors or organs to identify genetic mutations, biomarkers, or disease characteristics. Various technologies are employed in this process, including next-generation sequencing (NGS), polymerase chain reaction (PCR), fluorescence in-situ hybridization (FISH), immunohistochemistry (IHC), and others. Cancer panels used in this testing include both single-gene and multi-gene panels. These tests are applied in clinical and research settings, serving end users such as hospitals, research and academic institutes, clinical and diagnostic laboratories, among others.

The genomic cancer panel and profiling market research report is one of a series of new reports from The Business Research Company that provides genomic cancer panel and profiling market statistics, including the genomic cancer panel and profiling industry global market size, regional shares, competitors with the genomic cancer panel and profiling market share, detailed genomic cancer panel and profiling market segments, market trends, and opportunities, and any further data you may need to thrive in the genomic cancer panel and profiling industry. This genomic cancer panel and profiling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The genomic cancer panel and profiling market size has grown strongly in recent years. It will grow from $9.47 billion in 2024 to $10.31 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. Growth during the historic period can be attributed to the rising global cancer burden, increased use in clinical trials, expansion of diagnostic infrastructure, growing awareness of genetic testing, and increased government and research funding.

The genomic cancer panel and profiling market size is expected to see strong growth in the next few years. It will grow to $14.37 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. Growth in the forecast period is expected to be driven by the expansion of liquid biopsy applications, growing use in early detection, the continued growth in tailored therapies, and an increase in companion diagnostics approvals. Key trends in the forecast period include the integration of AI and machine learning for genomic data interpretation, the development of multi-omics approaches, cloud-based genomic data storage and analysis, integration with electronic health records, and the expansion of next-generation sequencing (NGS) platforms.

The increasing incidence of cancer is expected to drive the growth of the genomic cancer panel and profiling market. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells in the body. The rising cancer incidence is primarily due to factors such as an aging population, which increases the risk of cancer as people live longer. Genomic cancer panels and profiling are used to identify genetic mutations and biomarkers, facilitating personalized treatment plans and improving early detection and disease monitoring. For example, in January 2024, the American Cancer Society reported that approximately 20 million new cancer cases were diagnosed globally in 2022, resulting in 9.7 million deaths. With population growth, the global cancer burden is projected to rise to 35 million cases by 2050. Therefore, the increasing incidence of cancer will drive the growth of the genomic cancer panel and profiling market.

Major companies in the genomic cancer panel and profiling market are focusing on technological innovations, such as next-generation sequencers, which enhance the accuracy, speed, and comprehensiveness of cancer diagnostics. Next-generation sequencers are advanced DNA sequencing technologies that allow for rapid, high-throughput analysis of genetic material to identify mutations and other genomic features. For instance, in April 2025, QIAGEN N.V., a Netherlands-based biotechnology company, launched QIAseq panels designed for next-generation sequencers. These panels enable comprehensive genomic profiling by analyzing over 700 genes, targeting both research and clinical applications to improve cancer diagnostics and treatment strategies.

In June 2023, Quest Diagnostics, a US-based clinical laboratory company, acquired Haystack Oncology, a biotech firm specializing in liquid biopsy technologies for early cancer detection and monitoring. The acquisition expands Quest Diagnostics' capabilities in liquid biopsy and cancer detection, enhancing its genomic testing offerings.

Major players in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., and Predictive Oncology Inc.

North America was the largest region in the genomic cancer panel and profiling market in 2024. The regions covered in genomic cancer panel and profiling report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the genomic cancer panel and profiling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genomic cancer panel and profiling market consists of revenues earned by entities by providing services such as genetic mutation analysis, companion diagnostic testing, cancer risk assessment, and screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomic cancer panel and profiling market also includes sales of targeted gene panels, companion diagnostic kits, sequencing platforms and instruments, bioinformatics software, and analysis tools. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomic Cancer Panel And Profiling Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomic cancer panel and profiling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomic cancer panel and profiling ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomic cancer panel and profiling market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Tissue Testing: Solid Tissue Testing; Liquid Tissue Testing
• 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Fluorescence In-Situ Hybridization (FISH); Immunohistochemistry (IHC); Other Technologies
• 3) By Cancer Panel Type: Single-Gene Panel; Multi-Gene Panel
• 4) By Application: Clinical; Research
• 5) By End User: Hospitals; Research And Academic Institutes; Clinical And Diagnostic Laboratories; Other End Users
• Subsegments:
• 1) By Solid Tissue Testing: Biopsy Samples; Surgical Resection Samples; Formalin-Fixed Paraffin-Embedded (FFPE) Tissues; Fresh Frozen Tissues
• 2) By Liquid Tissue Testing: Blood; Urine; Saliva; Cerebrospinal Fluid (CSF); Other Bodily Fluids
• Companies Mentioned: Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Hologic Inc.; Illumina Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genomic Cancer Panel And Profiling Market Characteristics

3. Genomic Cancer Panel And Profiling Market Trends And Strategies

4. Genomic Cancer Panel And Profiling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Genomic Cancer Panel And Profiling Growth Analysis And Strategic Analysis Framework

• 5.1. Global Genomic Cancer Panel And Profiling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Genomic Cancer Panel And Profiling Market Growth Rate Analysis
• 5.4. Global Genomic Cancer Panel And Profiling Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Genomic Cancer Panel And Profiling Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Genomic Cancer Panel And Profiling Total Addressable Market (TAM)

6. Genomic Cancer Panel And Profiling Market Segmentation

• 6.1. Global Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solid Tissue Testing
• Liquid Tissue Testing
• 6.2. Global Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Fluorescence In-Situ Hybridization (FISH)
• Immunohistochemistry (IHC)
• Other Technologies
• 6.3. Global Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Gene Panel
• Multi-Gene Panel
• 6.4. Global Genomic Cancer Panel And Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical
• Research
• 6.5. Global Genomic Cancer Panel And Profiling Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research And Academic Institutes
• Clinical And Diagnostic Laboratories
• Other End Users
• 6.6. Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Solid Tissue Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopsy Samples
• Surgical Resection Samples
• Formalin-Fixed Paraffin-Embedded (FFPE) Tissues
• Fresh Frozen Tissues
• 6.7. Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Liquid Tissue Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood
• Urine
• Saliva
• Cerebrospinal Fluid (CSF)
• Other Bodily Fluids

7. Genomic Cancer Panel And Profiling Market Regional And Country Analysis

• 7.1. Global Genomic Cancer Panel And Profiling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Genomic Cancer Panel And Profiling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genomic Cancer Panel And Profiling Market

• 8.1. Asia-Pacific Genomic Cancer Panel And Profiling Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genomic Cancer Panel And Profiling Market

• 9.1. China Genomic Cancer Panel And Profiling Market Overview
• 9.2. China Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genomic Cancer Panel And Profiling Market

• 10.1. India Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genomic Cancer Panel And Profiling Market

• 11.1. Japan Genomic Cancer Panel And Profiling Market Overview
• 11.2. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genomic Cancer Panel And Profiling Market

• 12.1. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genomic Cancer Panel And Profiling Market

• 13.1. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genomic Cancer Panel And Profiling Market

• 14.1. South Korea Genomic Cancer Panel And Profiling Market Overview
• 14.2. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genomic Cancer Panel And Profiling Market

• 15.1. Western Europe Genomic Cancer Panel And Profiling Market Overview
• 15.2. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genomic Cancer Panel And Profiling Market

• 16.1. UK Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genomic Cancer Panel And Profiling Market

• 17.1. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genomic Cancer Panel And Profiling Market

• 18.1. France Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genomic Cancer Panel And Profiling Market

• 19.1. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genomic Cancer Panel And Profiling Market

• 20.1. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genomic Cancer Panel And Profiling Market

• 21.1. Eastern Europe Genomic Cancer Panel And Profiling Market Overview
• 21.2. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genomic Cancer Panel And Profiling Market

• 22.1. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genomic Cancer Panel And Profiling Market

• 23.1. North America Genomic Cancer Panel And Profiling Market Overview
• 23.2. North America Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genomic Cancer Panel And Profiling Market

• 24.1. USA Genomic Cancer Panel And Profiling Market Overview
• 24.2. USA Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genomic Cancer Panel And Profiling Market

• 25.1. Canada Genomic Cancer Panel And Profiling Market Overview
• 25.2. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genomic Cancer Panel And Profiling Market

• 26.1. South America Genomic Cancer Panel And Profiling Market Overview
• 26.2. South America Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genomic Cancer Panel And Profiling Market

• 27.1. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genomic Cancer Panel And Profiling Market

• 28.1. Middle East Genomic Cancer Panel And Profiling Market Overview
• 28.2. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genomic Cancer Panel And Profiling Market

• 29.1. Africa Genomic Cancer Panel And Profiling Market Overview
• 29.2. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genomic Cancer Panel And Profiling Market Competitive Landscape And Company Profiles

• 30.1. Genomic Cancer Panel And Profiling Market Competitive Landscape
• 30.2. Genomic Cancer Panel And Profiling Market Company Profiles
  • 30.2.1. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Genomic Cancer Panel And Profiling Market Other Major And Innovative Companies

• 31.1. Sysmex Corporation
• 31.2. QIAGEN N.V.
• 31.3. Exact Sciences Corporation
• 31.4. ARUP Laboratories
• 31.5. Tempus Labs
• 31.6. Genscript Biotech Corporation
• 31.7. NeoGenomics Inc.
• 31.8. Foundation Medicine
• 31.9. Invitae Corporation
• 31.10. Guardant Health Inc.
• 31.11. Caris Life Sciences
• 31.12. Fulgent Genetics
• 31.13. NanoString Technologies Inc.
• 31.14. Genecast Biotechnology Co. Ltd
• 31.15. Burning Rock DX

32. Global Genomic Cancer Panel And Profiling Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomic Cancer Panel And Profiling Market

34. Recent Developments In The Genomic Cancer Panel And Profiling Market

35. Genomic Cancer Panel And Profiling Market High Potential Countries, Segments and Strategies

• 35.1 Genomic Cancer Panel And Profiling Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Genomic Cancer Panel And Profiling Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Genomic Cancer Panel And Profiling Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer